Related Experiment Videos
Insulin resistance in a boy with congenital generalized lipodystrophy
H Tsukahara1, K Kikuchi, H Kuzuya
1Kyoto University School of Medicine.
Insights
This study investigated insulin resistance in a boy with congenital generalized lipodystrophy, revealing impaired insulin sensitivity and responsiveness. The findings suggest a potential post-binding defect in insulin action, possibly related to glucose transport.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Molecular Biology
Background:
- Congenital generalized lipodystrophy is a rare disorder characterized by a near-total absence of adipose tissue.
- Insulin resistance is a common complication of lipodystrophy, but its underlying mechanisms can be complex.
Abstract:
We have studied insulin resistance in a 12-year-old Japanese boy who presented with congenital generalized lipodystrophy. Oral glucose tolerance test exhibited a diabetic pattern with normal fasting plasma glucose. Results from euglycemic glucose clamp study showed decreases in both insulin sensitivity and responsiveness. Both the patient's erythrocytes and Epstein-Barr virus transformed lymphocytes showed low-normal insulin binding with a slight reduction in binding affinity in the latter. Insulin binding to the cultured fibroblasts was decreased due to a lowered affinity. In addition, they displayed a rightward shift of the insulin dose-response curve for D-14C-glucose uptake with no decrease in the maximum uptake. Insulin-stimulated autophosphorylation and kinase activity of the wheat germ agglutinin purified receptors from the Epstein-Barr virus-transformed lymphocytes appeared normal. The reason for some discrepancies in insulin binding among the cells remains unknown, and we cannot formulate a conclusion as to whether or not a primary binding defect of insulin receptors exists and contributes to insulin resistance in the patient. The decrease in insulin responsiveness demonstrated in the glucose clamp study may result from a defect at the rate-limiting step in the postbinding process of insulin action, presumably a defect in the glucose transport system in muscle tissues. The defect may be secondary to changes in in vivo circumstances.